There has been controversy around aducanumab, which targets the cause rather than the symptoms.
US approves first new Alzheimer’s drug in 20 years
feel free to call us +646-389-3981 info@mmnofa.com
-
UK to bake in 33C amid extreme heat warning
admin, , TOP STORIES, 0
Parts of Wales and southern and central England could be hotter than Tenerife and Marbella later.
-
Driving innovation with emotional intelligence
admin, , TOP STORIES, 0
The world watched in wonder in February as NASA’s robotic rover Perseverance successfully landed on the surface of Mars...
-
Ukraine War: Counter-offensive troops punch through Russia line, generals claim
admin, , TOP STORIES, 0
Kyiv says its troops are gaining momentum in what continues to be a lengthy and bloody counter-offensive.
-
How to talk to vaccine-hesitant people
admin, , TOP STORIES, 0
Even those who might seem to fit the stereotype at first glance may have more to their story. Steward,...
-
Tackling our biggest problems
admin, , TOP STORIES, 0
We have employed it to broadcast hateful rhetoric and divisive ideologies. We have fine-tuned our machines to kill each...
-
Coronavirus: Plan to exit lockdown ‘cautious but irreversible’, says Boris Johnson
admin, , TOP STORIES, 0
Boris Johnson says the government will set out its plans on 22 February, which could include target dates.
-
COP26: Greta Thunberg tells protest that COP26 has been a ‘failure’
admin, , TOP STORIES, 0
The Swedish activist was speaking after thousands of climate protestors marched through Glasgow.
-
Covid-19: Dover port halts exports to France for 48 hours
admin, , TOP STORIES, 0
France is to stop lorries arriving from the UK amid concern over a new variant of coronavirus.
Recent Posts
Archives
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2013
Recent Comments